Monthly Archives: January 2021

COVID 19. Update #3

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #21.4     COVID 19. Update #3     The past week news flow has been particularly rich with nevertheless three topics on the forefront:  vaccine supplies, rapid emergence of new SARS-CoV-2 variants, debate on the use of antibodies to treat […]

read more

Helping you to prepare next BIO-EUROPE SPRING March 22-25, 2021

If you lack time to prepare your next business convention, we could help you ! Outsourced the preparation of your next Bio-Business Convention You would like to take part to next Bio Business convention (BIO-EUROPE Spring  Digital , BIO-US, or other Business conventions). But a good preparation for a business convention is time-consuming and you have more important task to do. […]

read more

COVID 19 Treatments Update #2

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #21.3     COVID 19 Treatments Update #2     In spite of the numerous announcements made at the JP Morgan Healthcare Conference this week, COVID-19 treatments remain the main topic of the Biopharmaceutical companies’ agenda At the dawn of the […]

read more

Novel Drug Approvals for 2020

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com       SPECIAL REPORT #21.2     Novel Drug Approvals for 2020     According to a report issued by the U.S. FDA’s Center for Drug Evaluation and Research (CDER) the agency has approved  53 new drugs and biological products in 2020. If one […]

read more

COVID-19 Vaccines: Update #1 (21)

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #21.1   We wish all our readers and friends a Happy and Healthy Year 2021.   COVID-19 Vaccines: Update 1     The past year has been unusual through many aspects but the emergence, in January 2020, of the SARS-CoV-2 virus […]

read more